BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 35996248)

  • 21. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
    Tang Y; Zhang Y; Hu X
    Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning.
    Hammad A; Elshaer M; Tang X
    Math Biosci Eng; 2021 Oct; 18(6):8997-9015. PubMed ID: 34814332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of potential biomarkers of vascular calcification using bioinformatics analysis and validation
    Chen C; Wu Y; Lu HL; Liu K; Qin X
    PeerJ; 2022; 10():e13138. PubMed ID: 35313524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioinformatic analysis of potential hub genes in gastric adenocarcinoma.
    Liu H; Qu Y; Zhou H; Zheng Z; Zhao J; Zhang J
    Sci Prog; 2021; 104(1):368504211004260. PubMed ID: 33788653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis.
    Chen B; Sun D; Qin X; Gao XH
    Invest New Drugs; 2021 Aug; 39(4):928-948. PubMed ID: 33501609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and clinicopathological analysis of potential p73-regulated biomarkers in colorectal cancer via integrative bioinformatics.
    Bareja C; Dwivedi K; Uboveja A; Mathur A; Kumar N; Saluja D
    Sci Rep; 2024 Apr; 14(1):9894. PubMed ID: 38688978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
    Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
    BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis.
    Yu-Jing T; Wen-Jing T; Biao T
    Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
    Shang M; Zhang L; Chen X; Zheng S
    Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bioinformatics analysis of COL1A1 regulated by miR-129-5p as a potential therapeutic target for gastric cancer].
    Yang W; Pan Y; Guan P; Li X; You C
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 May; 39(5):540-546. PubMed ID: 31140417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer.
    Yang G; Jian L; Lin X; Zhu A; Wen G
    Dis Markers; 2019; 2019():1372571. PubMed ID: 31949544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis.
    Guo J; Gu Y; Ma X; Zhang L; Li H; Yan Z; Han Y; Xie L; Guo X
    J Cell Mol Med; 2020 Apr; 24(8):4428-4438. PubMed ID: 32147961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening and identification of key genes and pathways in metastatic uveal melanoma based on gene expression using bioinformatic analysis.
    Xie J; Wu Z; Xu X; Liang G; Xu J
    Medicine (Baltimore); 2020 Oct; 99(43):e22974. PubMed ID: 33120861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
    Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
    Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis.
    Yang Q; Li K; Li X; Liu J
    Int J Med Sci; 2020; 17(14):2063-2076. PubMed ID: 32922167
    [No Abstract]   [Full Text] [Related]  

  • 39. Five hub genes contributing to the oncogenesis and trastuzumab-resistance in gastric cancer.
    Chen F; Wang Y; Zhang X; Fang J
    Gene; 2023 Jan; 851():146942. PubMed ID: 36202277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.